Light-induced vs. bradykinin-induced relaxation of coronary arteries: Do S-nitrosothiols act as endothelium-derived hyperpolarizing factors?

Journal of Hypertension

Volumn 27, Issue 8, 2009, Pages 1631-1640

  Batenburg, Wendy W ^a   Kappers, Mariette H W ^a   Eikmann, Melissa J ^a   Ramzan, Serge N A ^a   De Vries, René ^a   Danser, Ah Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bradykinin; Endothelium derived hyperpolarizing factor; Nitric oxide synthase; Photorelaxation; S nitrosothiols

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; BRADYKININ; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; HYDROXOCOBALAMIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; S NITROSOTHIOL; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; CALCIUM CONDUCTANCE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; ENZYME INHIBITION; LIGHT; LIGHT EXPOSURE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE; SWINE;

EID: 68449103048     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832bff54     Document Type: Article

References (38)

1. Taddei S, Ghiadoni L, Virdis A, Buralli S, Salvetti A. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation 1999; 100:1400-1405.
2. Taddei S, Versari D, Cipriano A, Ghiadoni L, Galetta F, Franzoni F, et al. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol 2006; 48:508-515.
3. Busse R, Edwards G, Félétou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci 2002; 23:374-380.
4. Félétou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 2006; 26:1215-1225.
5. Weston AH, Félétou M, Vanhoutte PM, Falck JR, Campbell WB, Edwards G. Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids. Br J Pharmacol 2005; 145:775-784.
6. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996; 78:415-423.
7. Archer SL, Gragasin FS, Wu X, Wang S, McMurtry S, Kim DH, et al. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels. Circulation 2003; 107:769-776.
8. Batenburg WW, Garrelds IM, van Kats JP, Saxena PR, Danser AHJ. Mediators of bradykinin-induced vasorelaxation in human coronary microarteries. Hypertension 2004; 43:488-492.
9. Batenburg WW, Popp R, Fleming I, de Vries R, Garrelds IM, Saxena PR, et al. Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF? Br J Pharmacol 2004; 142:125-135.
10. Batenburg WW, de Vries R, Saxena PR, Danser AHJ. L-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries? J Hypertens 2004; 22:1927-1936.
11. Lang RJ, Harvey JR, Mulholland EL. Sodium (2-sulfonatoethyl) methanethiosulfonate prevents S-nitroso-L-cysteine activation of Ca2+·activated K+ (BK(Ca)) channels in myocytes of the guinea·pig taenia caeca. Br J Pharmacol 2003; 139:1153-1163.
12. Severina IS, Bussygina OG, Pyatakova NV, Malenkova IV, Vanin AF. Activation of soluble guanylate cyclase by NO donors - S-nitrosothiols, and dinitrosyl-iron complexes with thiol-containing ligands. Nitric Oxide 2003; 8:155-163.
13. Danser AHJ, de Vries R, Schoemaker RG, Saxena PR. Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factors. J Hypertens 1998; 16:239-244.
14. Lovren F, Triggle CR. Involvement of nitrosothiols, nitric oxide and voltage-gated K+ channels in photorelaxation of vascular smooth muscle. Eur J Pharmacol 1998; 347:215-221.
15. Davisson RL, Travis MD, Bates JN, Lewis SJ. Hemodynamic effects of L-and D-S-nitrosocysteine in the rat. Stereoselective S-nitrosothiol recognition sites. Circ Res 1996; 79:256-262.
16. Lewis SJ, Hoque A, Bates JN. Differentiation of L-and D-S-nitrosothiol recognition sites in vivo. J Cardiovasc Pharmacol 2005; 46:660-671.
17. Furchgott RF, Ehrreich SJ, Greenblatt E. The photoactivated relaxation of smooth muscle of rabbit aorta. J Gen Physiol 1961; 44:499-519.
18. Andrews KL, McGuire JJ, Triggle CR. A photosensitive vascular smooth muscle store of nitric oxide in mouse aorta: no dependence on expression of endothelial nitric oxide synthase. Br J Pharmacol 2003; 138:932-940.
19. Megson IL, Holmes SA, Magid KS, Pritchard RJ, Flitney FW. Selective modifiers of glutathione biosynthesis and Yepriming' of vascular smooth muscle photorelaxation. Br J Pharmacol 2000; 130:1575-1580.
20. Charpie JR, Peters A, Webb RC. A photoactivable source of relaxing factor in genetic hypertension. Hypertension 1994; 23:894-898.
21. Davisson RL, Travis MD, Bates JN, Johnson AK, Lewis SJ. Stereoselective actions of S-nitrosocysteine in central nervous system of conscious rats. Am J Physiol 1997; 272:H2361-H2368.
22. Richardson G, Benjamin N. Potential therapeutic uses for S-nitrosothiols. Clin Sci (Lond) 2002; 102:99-105.
23. Sogo N, Campanella C, Webb DJ, Megson IL S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery. Br J Pharmacol 2000; 131:1236-1244.
24. Rodriguez J, Maloney RE, Rassaf T, Bryan NS, Feelisch M. Chemical nature of nitric oxide storage forms in rat vascular tissue. Proc Natl Acad Sci U S A 2003; 100:336-341.
25. Hogg N. The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol 2002; 42:585-600.
26. Ng ES, Cheng ZJ, Ellis A, Ding H, Jiang Y, Li Y, et al. Nitrosothiol stores in vascular tissue: modulation by ultraviolet light, acetylcholine and ionomycin. Eur J Pharmacol 2007; 560:183-192.
27. Flitney FW, Megson IL. Nitric oxide and the mechanism of rat vascular smooth muscle photorelaxation. J Physiol 2003; 550:819-828.
28. Furchgott RF, Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 1991; 28:52-61.
29. Bauer JA, Fung HL. Photochemical generation of nitric oxide from nitro-containing compounds: possible relation to vascular photorelaxation phenomena. Life Sci 1994; 54:L1-L4.
30. Danser AHJ, Tom B, de Vries R, Saxena PR. L-NAME resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition. Br J Pharmacol 2000; 131:195-202.
31. Thollon C, Fournet-Bourguignon MP, Saboureau D, Lesage L, Reure H, Vanhoutte PM, et al. Consequences of reduced production of NO on vascular reactivity of porcine coronary arteries after angioplasty: importance of EDHF. Br J Pharmacol 2002; 136:1153-1161.
32. Bellien J, Iacob M, Gutierrez L, Isabelle M, Lahary A, Thuillez C, et al. Crucial role of NO and endothelium-derived hyperpolarizing factor in human sustained conduit artery flow-mediated dilatation. Hypertension 2006; 48:1088-1094.
33. Megson IL, Flitney FW, Bates J, Webster RN. 'Repriming' of vascular smooth muscle photorelaxation is dependent on endothelium-derived nitric oxide. Endothelium 1995; 3:39-46.
34. Venturini CM, Palmer RM, Moncada S. Vascular smooth muscle contains a depletable store of a vasodilator which is light-activated and restored by donors of nitric oxide. J Pharmacol Exp Ther 1993; 266:1497-1500.
35. Travis MD, Stoll LL, Bates JN, Lewis SJ. L-and D-S-nitroso-beta, beta-dimethylcysteine differentially increase cGMP in cultured vascular smooth muscle cells. Eur J Pharmacol 1996; 318:47-53.
36. Ceron PI, Cremonez DC, Bendhack LM, Tedesco AC. The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production. J Pharmacol Exp Ther 2001; 298:686-694.
37. Bawankule DU, Sathishkumar K, Sardar KK, Chanda D, Krishna AV, Prakash VR, et al. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H- pyrazolo[3,4-b]pyridine-3-yl]pyri midin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump. J Pharmacol Exp Ther 2005; 314:207-213.
38. Stasch JP, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M, et al. NO-and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol 2002; 136:773-783.